These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23586070)

  • 21. Concomitant detection of beta-amyloid peptides with N-terminal truncation and different C-terminal endings in cortical plaques from cases with Alzheimer's disease, senile monkeys and triple transgenic mice.
    Härtig W; Goldhammer S; Bauer U; Wegner F; Wirths O; Bayer TA; Grosche J
    J Chem Neuroanat; 2010 Sep; 40(1):82-92. PubMed ID: 20347032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gadolinium-staining reveals amyloid plaques in the brain of Alzheimer's transgenic mice.
    Petiet A; Santin M; Bertrand A; Wiggins CJ; Petit F; Houitte D; Hantraye P; Benavides J; Debeir T; Rooney T; Dhenain M
    Neurobiol Aging; 2012 Aug; 33(8):1533-44. PubMed ID: 21531045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A; Döbeli H; Bohrmann B
    Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraneuronal Aβ accumulation, amyloid plaques, and synapse pathology in Alzheimer's disease.
    Capetillo-Zarate E; Gracia L; Tampellini D; Gouras GK
    Neurodegener Dis; 2012; 10(1-4):56-9. PubMed ID: 22269167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of amyloid plaques in mouse models of Alzheimer's disease by magnetic resonance imaging.
    Zhang J; Yarowsky P; Gordon MN; Di Carlo G; Munireddy S; van Zijl PC; Mori S
    Magn Reson Med; 2004 Mar; 51(3):452-7. PubMed ID: 15004784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment.
    Leon WC; Canneva F; Partridge V; Allard S; Ferretti MT; DeWilde A; Vercauteren F; Atifeh R; Ducatenzeiler A; Klein W; Szyf M; Alhonen L; Cuello AC
    J Alzheimers Dis; 2010; 20(1):113-26. PubMed ID: 20164597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of Aβ plaque-associated astrogliosis in Alzheimer's disease brain by spectroscopic imaging and immunohistochemistry.
    Palombo F; Tamagnini F; Jeynes JCG; Mattana S; Swift I; Nallala J; Hancock J; Brown JT; Randall AD; Stone N
    Analyst; 2018 Feb; 143(4):850-857. PubMed ID: 29230441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative MRI reveals aging-associated T2 changes in mouse models of Alzheimer's disease.
    Falangola MF; Dyakin VV; Lee SP; Bogart A; Babb JS; Duff K; Nixon R; Helpern JA
    NMR Biomed; 2007 May; 20(3):343-51. PubMed ID: 17451178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease.
    DeMattos RB; Bales KR; Cummins DJ; Paul SM; Holtzman DM
    Science; 2002 Mar; 295(5563):2264-7. PubMed ID: 11910111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In situ structural characterization of early amyloid aggregates in Alzheimer's disease transgenic mice and Octodon degus.
    Benseny-Cases N; Álvarez-Marimon E; Aso E; Carmona M; Klementieva O; Appelhans D; Ferrer I; Cladera J
    Sci Rep; 2020 Apr; 10(1):5888. PubMed ID: 32246090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association among amyloid plaque, lipid, and creatine in hippocampus of TgCRND8 mouse model for Alzheimer disease.
    Kuzyk A; Kastyak M; Agrawal V; Gallant M; Sivakumar G; Rak M; Del Bigio MR; Westaway D; Julian R; Gough KM
    J Biol Chem; 2010 Oct; 285(41):31202-7. PubMed ID: 20682779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COB231 targets amyloid plaques in post-mortem human brain tissue and in an Alzheimer mouse model.
    Garin D; Virgone-Carlotta A; Gözel B; Oukhatar F; Perret P; Marti-Battle D; Touret M; Millet P; Dubois-Dauphin M; Meyronet D; Streichenberger N; Laferla FM; Demeunynck M; Chierici S; Sallanon Moulin M; Ghezzi C
    J Neurochem; 2015 Mar; 132(5):609-18. PubMed ID: 25258048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regional differences in MRI detection of amyloid plaques in AD transgenic mouse brain.
    Wengenack TM; Reyes DA; Curran GL; Borowski BJ; Lin J; Preboske GM; Holasek SS; Gilles EJ; Chamberlain R; Marjanska M; Jack CR; Garwood M; Poduslo JF
    Neuroimage; 2011 Jan; 54(1):113-22. PubMed ID: 20728546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In situ characterization of beta-amyloid in Alzheimer's diseased tissue by synchrotron Fourier transform infrared microspectroscopy.
    Choo LP; Wetzel DL; Halliday WC; Jackson M; LeVine SM; Mantsch HH
    Biophys J; 1996 Oct; 71(4):1672-9. PubMed ID: 8889145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synchrotron X-ray Fluorescence and FTIR Signatures for Amyloid Fibrillary and Nonfibrillary Plaques.
    Álvarez-Marimon E; Castillo-Michel H; Reyes-Herrera J; Seira J; Aso E; Carmona M; Ferrer I; Cladera J; Benseny-Cases N
    ACS Chem Neurosci; 2021 Jun; 12(11):1961-1971. PubMed ID: 33990138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Micro-Raman spectroscopy of lipid halo and dense-core amyloid plaques: aging process characterization in the Alzheimer's disease APPswePS1ΔE9 mouse model.
    Fonseca EA; Lafeta L; Luiz Campos J; Cunha R; Barbosa A; Romano-Silva MA; Vieira R; Malard LM; Jorio A
    Analyst; 2021 Sep; 146(19):6014-6025. PubMed ID: 34505596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FTIR imaging of the molecular burden around Aβ deposits in an early-stage 3-Tg-APP-PSP1-TAU mouse model of Alzheimer's disease.
    Surowka AD; Pilling M; Henderson A; Boutin H; Christie L; Szczerbowska-Boruchowska M; Gardner P
    Analyst; 2016 Dec; 142(1):156-168. PubMed ID: 27917428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperspectral analysis applied to micro-Brillouin maps of amyloid-beta plaques in Alzheimer's disease brains.
    Palombo F; Masia F; Mattana S; Tamagnini F; Borri P; Langbein W; Fioretto D
    Analyst; 2018 Dec; 143(24):6095-6102. PubMed ID: 30460364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of tauopathy-associated lipid signatures in Alzheimer's disease mouse brain using label-free chemical imaging.
    Meng H; Elliott A; Mansfield J; Bailey M; Frogley M; Cinque G; Moger J; Stone N; Tamagnini F; Palombo F
    Commun Biol; 2024 Oct; 7(1):1341. PubMed ID: 39420210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.